A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF LAMPALIZUMAB IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION WHO HAVE COMPLETED A ROCHE¿SPONSORED STUDY
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
August 15, 2016
End Date
July 3, 2019
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
August 15, 2016
End Date
July 3, 2019